<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Verve Motion — Prospect Detail</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>
<header class="site-header"><h1>Prospect Detail</h1></header>
<div class="container">
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
  <div class="detail-header">
    <span class="badge other" style="font-size:.8rem;">Robotics / Industrial</span>
    <h1>139. Verve Motion</h1>
    <p class="meta">SafeLift Exosuit Reducing 30-40% Back Strain</p>
  </div>
  <div class="section"><h3>1. Startup Name</h3><p><strong>Verve Motion</strong></p>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Tell me more about this company's origin story...">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="section"><h3>2. Founder Contact</h3><p><strong>Ignacio Galiana & Conor Walsh</strong></p><p>Wyss Institute</p><p>Dr. Walsh is a pioneer in soft robotics and wearable exosuits; team developed the technology originally for DARPA</p>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Research the founder's background and credentials...">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="section"><h3>3. Product Overview</h3><p>Verve Motion develops the SafeLift exosuit, a wearable powered device that reduces back strain by 30-40% for workers performing repetitive lifting and bending tasks. Unlike rigid exoskeletons, the soft exosuit design from the Walsh lab at the Wyss Institute is lightweight, comfortable for all-day wear, and doesn't restrict natural movement. The system is deployed in warehouses, manufacturing, and logistics to reduce workplace injuries and improve worker productivity.</p>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="What competitors does this product face?">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="section"><h3>4. Funding Stage</h3><p><strong>Series A — $40M</strong> — Scaling commercial deployment and expanding customer base.</p>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="What's the typical next funding milestone?">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="section"><h3>5. How I Found the Company</h3><p>Discovered through Wyss Institute portfolio and industrial exoskeleton market research.</p>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Find more recent news about this company...">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="strengths-weaknesses">
    <div class="section"><h3>Strengths</h3><ul><li><strong>Proven technology:</strong> Walsh lab's soft robotics tech validated through DARPA funding and extensive research.</li><li><strong>Clear ROI:</strong> Back injuries cost employers billions annually; 30-40% strain reduction is measurable.</li><li><strong>Soft design advantage:</strong> More comfortable and practical than rigid exoskeletons for all-day wear.</li></ul>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Validate these strengths with market data...">
        <button>Ask AI</button>
      </div>
    </div>
    </div>
    <div class="section"><h3>Weaknesses</h3><ul><li><strong>Enterprise sales cycle:</strong> Selling to large industrial customers involves lengthy procurement processes.</li><li><strong>Competitive market:</strong> Multiple exoskeleton companies targeting industrial applications.</li><li><strong>Adoption friction:</strong> Worker acceptance and training requirements for new technology.</li></ul>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="What other risks should I consider?">
        <button>Ask AI</button>
      </div>
    </div>
    </div>
  </div>
  <div class="section"><h3>7. Five Questions for the Team</h3><ol class="questions-list"><li>What is your current customer count and deployment scale?</li><li>How do you measure and verify the 30-40% strain reduction claims?</li><li>What is your unit economics — device cost, subscription model, or per-worker pricing?</li><li>Which industries have been fastest to adopt and why?</li><li>How do you compete with rigid exoskeleton alternatives from companies like Ekso Bionics?</li></ol>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Generate additional due diligence questions...">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <div class="section email-draft">
    <h3>8. Draft Outreach Email</h3>
    <div class="email-box">
      <p><strong>Subject:</strong> Harvard Undergraduate Capital Partners — Soft Robotics from Wyss</p>
      <p>Hi Ignacio,</p>
      <p>I'm reaching out from <strong>Harvard Undergraduate Capital Partners (HUCP)</strong>, a student-run investment group at Harvard focused on early-stage ventures led by Harvard-affiliated founders.</p>
      <p>We've been following Verve Motion's SafeLift exosuit with great interest. The application of Dr. Walsh's pioneering soft robotics research from the Wyss Institute to protect industrial workers from back injuries is compelling — both as a business opportunity and a genuine improvement in worker safety. The 30-40% strain reduction you've demonstrated could prevent countless injuries.</p>
      <p>Would you be open to a brief conversation about Verve Motion's journey from DARPA-funded research to commercial deployment? We'd love to learn more about your scaling strategy and explore how HUCP might support your growth.</p>
      <p>Looking forward to connecting.</p>
      <p>Best,<br>[Your Name]<br>Harvard Undergraduate Capital Partners</p>
    </div>
    <div class="ai-dialogue">
      <div class="ai-dialogue-label">Ask AI to verify or expand</div>
      <div class="ai-dialogue-input">
        <input type="text" placeholder="Personalize this email with more specific details...">
        <button>Ask AI</button>
      </div>
    </div>
  </div>
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
</div>
<script src="script.js?v=4"></script>
</body>
</html>
